Filing Details

Accession Number:
0000899243-20-014050
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-22 17:44:43
Reporting Period:
2020-05-20
Accepted Time:
2020-05-22 17:44:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1735438 Meiragtx Holdings Plc MGTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1742734 Richard Giroux 450 E. 29Th Street, 14Th Floor
New York NY 10016
Cfo & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2020-05-20 6,143 $15.03 1,076,304 No 4 S Direct
Ordinary Shares Disposition 2020-05-21 11,786 $15.16 1,064,518 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 5,152 Indirect By Spouse
Ordinary Shares 85,000 Indirect By Aigle Healthcare Partners III LLC
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2019.
  2. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.15, inclusive.
  3. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  4. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.37, inclusive.